Sage’s cognition drug fails in Parkinson’s study
Bio Pharma Dive
APRIL 17, 2024
Other studies in Huntington’s and Alzheimer’s remain ongoing. Following negative results, the company doesn’t plan to further test SAGE-718 in Parkinson’s.
studies 
164 
Gritstone to lay off 40% of workforce after costly study delay
Bio Pharma Dive
MARCH 1, 2024
The restructuring comes ahead of a key study readout for Gritstone, which, like Moderna, is developing a type of personalized vaccine for cancer.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Verve pauses base editing study after treatment side effect
Bio Pharma Dive
APRIL 2, 2024
Lab test abnormalities in one study participant led the company to halt enrollment and prioritize a different version of its gene editing therapy for heart disease.
Pioneer Institute study finds IRA discourages non-opioid drug innovation
Pharmaceutical Technology
APRIL 26, 2024
The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
How can you reliably supply these studies? Planning on running clinical trials in Japan? Discover Catalent’s clinical supply packaging facility in Shiga, Japan.
Gilead ADC medicine misses goal in closely watched lung cancer study
Bio Pharma Dive
JANUARY 22, 2024
Trodelvy didn’t outperform chemotherapy in a large study of people with a common lung tumor, a setback that sent company shares down by double digits.
Optimizing Data Collection in Post-Surgical Pain Studies & The Role of Clinical Assessments
Worldwide Clinical Trials
APRIL 25, 2024
However, the collection of accurate and reliable data in these pain studies presents a unique set of challenges, from the subjective nature of pain to the variability in patient compliance and assessment methodologies. However, further improvements are needed , including: Refinement of trial designs that address specific factors (e.g.,
The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Commercial Drug Sourcing for Clinical Trials
Advertisement
Sponsors can face a number of challenges when trying to obtain these critical supplies for their studies, including addressing product lead times, availability, expiry limitations, safety and cost, among others.
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
Having a team of individuals with specialized expertise in different areas of clinical supply—including protocol review and early operational planning, to managing the development and execution of a sound clinical supply strategy—can prove invaluable to the overall suitability and performance of the supply chain, and in turn, the successful execution (..)
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management.
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Let's personalize your content